Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients

C. Lemos, E. Giovannetti, P.A. Zucali, Y.G. Assaraf, G.L. Scheffer, T. van der Straaten, A. D'Incecco, A. Falcone, H.J. Guchelaar, R. Danesi, A. Santoro, G. Giaccone, C. Tibaldi, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)159-170
JournalPharmacogenomics
Volume12
Issue number2
DOIs
Publication statusPublished - 2011

Cite this